Regulatory feasibility assessment is one of the most important and first steps in conducting a clinical trial. It helps evaluate the compatibility of a clinical trial design, adhere to current regulatory requirements and compliances, and focus on safety and efficiency to conduct a proper clinical trial. This phenomenon works as a bridge between regulatory requirements […]

Read More →

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous, or granulocytic leukemia. Causes of AML The causes of AML remain largely […]

Read More →